Skip to main content
SpringerLink
Log in
Book cover

Psychological Aspects of Cancer pp 255–278Cite as

Quality of Life

  • Chapter
  • First Online:

  • 2589 Accesses

Abstract

Research in the past three decades has seen a burgeoning interest in quality of life for cancer patients and survivors. Driven by patient-report and multidimensional in nature, health-related quality of life has emerged as an important outcome in cancer clinical trials and has thus informed treatment decision-making. The purpose of this chapter is to provide an overview of the various types and dimensions of HRQOL measurement and describe their relevance for use across the continuum of cancer care. In addition, several emerging issues and applications of HRQOL research are described. Future work can benefit from sophisticated measurement approaches that maximize the precision, flexibility, and brevity of HRQOL measurement while providing meaningful information to patients and providers that can inform treatment-related decisions and be linked to clinical benchmarks.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. National Cancer Institute. Estimated US cancer prevalence counts: who are our cancer survivors in the U.S.? http://cancercontrol.cancer.gov/ocs/prevalence/index.html. Accessed 16 Sept 2011.

  2. American Cancer Society. Cancer facts & figures 2011. Atlanta: American Cancer Society; 2011.

    Google Scholar 

  3. Zafar S, Alexander S, Weinfurt K, Schulman K, Abernethy A. Decision making and quality of life in the treatment of cancer: a review. Support Care Cancer. 2009;17(2):117–27.

    Article  PubMed  Google Scholar 

  4. U. S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. 2009. http://purl.access.gpo.gov/GPO/LPS113413.

  5. WHOQOL. Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res. 1993;2(2):153–9.

    Article  Google Scholar 

  6. Morton RP, Izzard ME. Quality-of-life Outcomes in Head and Neck Cancer Patients. World J Surg. 2003;27(7):884–9.

    Article  PubMed  Google Scholar 

  7. Cella DF. Quality of life concepts and definition. J Pain Symptom Manage. 1994;9(3):186–92.

    Article  PubMed  CAS  Google Scholar 

  8. Cella DF. Methods and problems in measuring quality of life. Support Care Cancer. 1995;3(1):11–22.

    Article  PubMed  CAS  Google Scholar 

  9. Kornblith AB, Holland JC, Memorial Sloan-Kettering Cancer Center. Handbook of measures for psychological, social and physical function in cancer., Quality of life, vol. 1. New York: Memorial Sloan-Kettering Cancer Center; 1994.

    Google Scholar 

  10. Cella D. Quality of life. In: Breitbart W, Holland JC, Jacobsen PB, et al., editors. Psycho-oncology. New York, Oxford: Oxford University Press; 1998. p. 1135–46.

    Google Scholar 

  11. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.

    Article  PubMed  Google Scholar 

  12. Ware Jr J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.

    Article  PubMed  Google Scholar 

  13. Ware JE, Snow KK, Kosinski M. SF-36 health survey: manual and interpretation guide. Lincoln, RI: QualityMetric Incorporated; 2000.

    Google Scholar 

  14. Stewart AL, Sherbourne CD, Hays R, et al. Summary and discussion of MOS measures. In: Stewart AL, Ware JE, editors. Measuring functioning and well-being: the medical outcomes study approach. Durham: Duke University Press; 1992. p. 345–71.

    Google Scholar 

  15. Bower JE, Ganz PA, Desmond KA, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106(4):751–8.

    Article  PubMed  Google Scholar 

  16. Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L. Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol. 2002;20(13):2920–9.

    Article  PubMed  Google Scholar 

  17. Alibhai SMH, Breunis H, Timilshina N, et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol. 2010;28(34):5038–45.

    Article  PubMed  CAS  Google Scholar 

  18. Hao Y, Stein K, Landrine H, Smith T, Kaw C, Corral I. Residential segregation and disparities in health-related quality of life among black and white cancer survivors. Health Psychol. 2011;30(2):137–44.

    Article  PubMed  Google Scholar 

  19. Hunt S, McKenna S, McEwen J, Williams J, Papp E. The Nottingham health profile: subjective health status and medical consultations. Soc Sci Med. 1981;55(2):301–11.

    Google Scholar 

  20. Franks PJ, Moffatt CJ. Health related quality of life in patients with venous ulceration: use of the Nottingham health profile. Qual Life Res. 2001;10(8):693–700.

    Article  PubMed  CAS  Google Scholar 

  21. Jans MP, Schellevis FG, van Eijk JTM. The Nottingham health profile: score distribution, internal consistency and validity in asthma and COPD patients. Qual Life Res. 1999;8(6):501–7.

    Article  PubMed  CAS  Google Scholar 

  22. Joly F, Espie M, Marty M, Heron JF, Henry-Amar M. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy. Br J Cancer. 2000;83(5):577–82.

    Article  PubMed  CAS  Google Scholar 

  23. Whynes DK, Neilson AR. Symptoms before and after surgery for colorectal cancer. Qual Life Res. 1997;6:61–6.

    Article  PubMed  CAS  Google Scholar 

  24. Ozalevli S, Ilgin D, Kul Karaali H, Bulac S, Akkoclu A. The effect of in-patient chest physiotherapy in lung cancer patients. Support Care Cancer. 2010;18(3):351–8.

    Article  PubMed  Google Scholar 

  25. Derogatis LR, Lopez MC. Psychosocial adjustment to illness scale: administration, scoring and procedures manual. Baltimore, MD: Johns Hopkins University School of Medicine; 1983.

    Google Scholar 

  26. Nishigaki M, Kazuma K, Oya M, et al. The influence of life stage on psychosocial adjustment in colorectal cancer patients. J Psychosoc Oncol. 2007;25(4):71–87.

    Article  PubMed  Google Scholar 

  27. Lemieux J, Beaton D, Hogg-Johnson S, Bordeleau L, Hunter J, Goodwin P. Responsiveness to change to change due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer. Qual Life Res. 2007;16(6):1007–17.

    Article  PubMed  Google Scholar 

  28. Peppercorn J, Herndon J, Kornblith AB, et al. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy. Cancer. 2005;104(8):1580–9.

    Article  PubMed  Google Scholar 

  29. Fortner BV, Schwartzberg L, Tauer K, Houts AC, Hackett J, Stolshek BS. Impact of chemotherapy-induced neutropenia on quality of life: a prospective pilot investigation. Support Care Cancer. 2005;13(7):522–8.

    Article  PubMed  Google Scholar 

  30. Merluzzi TV, Sanchez MAM. Factor structure of the psychosocial adjustment to illness scale (self-report) for persons with cancer. Psychol Assess. 1997;9(3):269–76.

    Article  Google Scholar 

  31. Kornblith AB, Herndon JE, Zuckerman E, et al. Comparison of psychosocial adaptation of advanced stage Hodgkin’s disease and acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol. 1998;9(3):297–306.

    Article  PubMed  CAS  Google Scholar 

  32. Bekkers MJ, van Knippenberg FC, van Dulmen AM, van den Borne HW, van Berge Henegouwen GP. Survival and psychosocial adjustment to stoma surgery and nonstoma bowel resection a 4-year follow-up. J Psychosom Res. 1997;42(3):235–44.

    Article  PubMed  CAS  Google Scholar 

  33. Olweny CL, Juttner CA, Rofe P, et al. Long-term effects of cancer treatment and consequences of cure: cancer survivors enjoy quality of life similar to their neighbours. Eur J Cancer. 1993;29A(6):826–30.

    Article  PubMed  CAS  Google Scholar 

  34. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care. 1981;19(8):787–805.

    Article  PubMed  CAS  Google Scholar 

  35. de Bruin AF, de Witte LP, Stevens F, Diederiks JP. Sickness impact profile: the state of the art of a generic functional status measure. Soc Sci Med. 1992;35(8):1003–14.

    Article  PubMed  Google Scholar 

  36. Pollard B, Johnston M. Problems with the sickness impact profile: a theoretically based analysis and a proposal for a new method of implementation and scoring. Soc Sci Med. 2001;52(6):921–34.

    Article  PubMed  CAS  Google Scholar 

  37. Blinderman CD, Homel P, Andrew Billings J, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage. 2009;38(1):115.

    Article  PubMed  Google Scholar 

  38. Ahlström G, Lindvall B, Wenneberg S, Gunnarsson LG. A comprehensive rehabilitation programme tailored to the needs of adults with muscular dystrophy. Clin Rehabil. 2006;20(2):132–41.

    Article  PubMed  Google Scholar 

  39. Selby PJ, Chapman JA, Etazadi-Amoli J, Dalley D, Boyd NF. The development of a method for assessing the quality of life of cancer patients. Br J Cancer. 1984;50(1):13–22.

    Article  PubMed  CAS  Google Scholar 

  40. Heitzmann CA, Merluzzi TV, Jean-Pierre P, Roscoe JA, Kirsh KL, Passik SD. Assessing self-efficacy for coping with cancer: development and psychometric analysis of the brief version of the Cancer Behavior Inventory (CBI-B). Psychooncology. 2011;20(3):302–12.

    Article  PubMed  Google Scholar 

  41. Gielissen MF, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol. 2006;24(30):4882–7.

    Article  PubMed  Google Scholar 

  42. Vargas S, Wohlgemuth WK, Antoni MH, Lechner SC, Holley HA, Carver CS. Sleep dysfunction and psychosocial adaptation among women undergoing treatment for non-metastatic breast cancer. Psychooncology. 2010;19(6):669–73.

    PubMed  Google Scholar 

  43. Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis. 1981;34(12):585–97.

    Article  PubMed  CAS  Google Scholar 

  44. Hird A, Wong J, Zhang L, et al. Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer quality of life index. Support Care Cancer. 2010;18(3):335–42.

    Article  PubMed  Google Scholar 

  45. Bonnetain F, Paoletti X, Collette S, et al. Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials. Qual Life Res. 2008;17(6):831–43.

    Article  PubMed  Google Scholar 

  46. Scott C, Suh J, Stea B, Nabid A, Hackman J. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (efaproxyn) plus whole-brain radiation therapy for brain metastases. Am J Clin Oncol. 2007;30(6):580–7. 510.1097/COC.1090b1013e3180653c3180650d.

    Article  PubMed  CAS  Google Scholar 

  47. Ganz PA, Schag CAC, Lee JJ, Sim MS. The CARES a generic measure of health-related quality of life for patients with cancer. Qual Life Res. 1992;1(1):19–29.

    Article  PubMed  CAS  Google Scholar 

  48. Schag CAC, Ganz PA, Heinrich RL. Cancer Rehabilitation Evaluation System-Short Form (CARES-SF): a cancer specific rehabilitation and quality of life instrument. Cancer. 1991;68(6):1406–13.

    Article  PubMed  CAS  Google Scholar 

  49. Schag CA, Ganz PA, Polinsky ML, Fred C, Hirji K, Petersen L. Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol. 1993;11(4):783–93.

    PubMed  CAS  Google Scholar 

  50. Schag CA, Ganz PA, Wing DS, Sim MS, Lee JJ. Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res. 1994;3(2):127–41.

    Article  PubMed  CAS  Google Scholar 

  51. Hawighorst S, Schoenefuss G, Fusshoeller C, et al. The physician-patient relationship before cancer treatment: a prospective longitudinal study. Gynecol Oncol. 2004;94(1):93–7.

    Article  PubMed  Google Scholar 

  52. Hjermstad MJ, Evensen SA, Kvaløy SO, Loge JH, Fayers PM, Kaasa S. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation. Psychooncology. 2003;12(8):803–13.

    Article  PubMed  Google Scholar 

  53. Casso D, Buist DS, Taplin S. Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes. 2004;2:25.

    Article  PubMed  Google Scholar 

  54. Clough-Gorr KM, Ganz PA, Silliman RA. Older breast cancer survivors: factors associated with change in emotional well-being. J Clin Oncol. 2007;25(11):1334–40.

    Article  PubMed  Google Scholar 

  55. Gotay CC, Moinpour CM, Unger JM, et al. Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. J Clin Oncol. 2007;25(15):2093–9.

    Article  PubMed  Google Scholar 

  56. Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst. 2000;92(13):1054–64.

    Article  PubMed  CAS  Google Scholar 

  57. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.

    Article  PubMed  CAS  Google Scholar 

  58. Aaronson NK, Ahmedzai S, Bullinger M, Osoba D. The EORTC core quality of life questionnaire: interim results of an international field study. In: Osoba D, editor. Effect of cancer on quality of life. Boca Raton, FL: CRC Press, Inc.; 1991.

    Google Scholar 

  59. Osoba D, Aaronson NK, Muller M, et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res. 1996;5(1):139–50.

    Article  PubMed  CAS  Google Scholar 

  60. Sprangers MA, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–68.

    PubMed  CAS  Google Scholar 

  61. Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, et al. The European Organization for Research and Treatment of Cancer (EORTC) quality-of-life questionnaire cervical cancer module: EORTC QLQ-CX24. Cancer. 2006;107(8):1812–22.

    Article  PubMed  Google Scholar 

  62. Sprangers MAG, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). Eur J Cancer. 1999;35(2):238–47.

    Article  PubMed  CAS  Google Scholar 

  63. Greimel E, Radisic VB, Daghofer F, et al. Psychometric validation of the European organisation for research and treatment of cancer quality of life questionnaire-endometrial cancer module (EORTC QLQ-EN24). Eur J Cancer. 2011;47(2):183–90.

    Article  PubMed  Google Scholar 

  64. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol. 1999;17(3):1008–19.

    PubMed  CAS  Google Scholar 

  65. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer. 1994;30(5):635–42.

    Article  Google Scholar 

  66. Stead ML, Brown JM, Velikova G, et al. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Br J Haematol. 1999;104(3):605–11.

    Article  PubMed  CAS  Google Scholar 

  67. Lagergren P, Fayers P, Conroy T, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer. 2007;43(14):2066–73.

    Article  PubMed  Google Scholar 

  68. Greimel E, Bottomley A, Cull A, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer. 2003;39(10):1402–8.

    Article  PubMed  CAS  Google Scholar 

  69. Fitzsimmons D, Johnson CD, George S, et al. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer. 1999;35(6):939–41.

    Article  PubMed  CAS  Google Scholar 

  70. Fossa SD, Aaronson NK, Newling D, et al. Quality of life and treatment of hormone resistant metastatic prostatic cancer. The EORTC Genito-Urinary Group. Eur J Cancer. 1990;26(11–12):1133–6.

    PubMed  CAS  Google Scholar 

  71. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.

    PubMed  CAS  Google Scholar 

  72. Bonomi P, Kim K, Fairclough D, et al. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J Clin Oncol. 2000;18(3):623–31.

    PubMed  CAS  Google Scholar 

  73. Cella DF, Tulsky DS. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest. 1993;11(3):327–36.

    Article  PubMed  CAS  Google Scholar 

  74. Cella D. Measuring quality of life in palliative care. Semin Oncol. 1995;22(2 Suppl 3):73–81.

    PubMed  CAS  Google Scholar 

  75. Dow KH, Ferrell BR, Leigh S, Ly J, Gulasekaram P. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat. 1996;39(3):261–73.

    Article  PubMed  CAS  Google Scholar 

  76. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50(6):920–8.

    Article  PubMed  CAS  Google Scholar 

  77. Esteve-Vives J, Batlle-Gualda E, Reig A. Spanish version of the health assessment questionnaire: reliability, validity and transcultural equivalency. Grupo para la Adaptacion del HAQ a la Poblacion Espanola. J Rheumatol. 1993;20(12):2116–22.

    PubMed  CAS  Google Scholar 

  78. Lee WR, McQuellon RP, Case LD, deGuzman AF, McCullough DL. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer. J Urol. 1999;162(2):403–6.

    Article  PubMed  CAS  Google Scholar 

  79. Litwin M, Hays RD, Fink A, et al. Quality of life outcomes in men treated for localized prostate cancer. J Am Med Assoc. 1995;273:129–35.

    Article  CAS  Google Scholar 

  80. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes: prostate carcinoma patients’ perspectives after prostatectomy or radiation therapy. Cancer. 1997;79(10):1977–86.

    Article  PubMed  CAS  Google Scholar 

  81. Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast (FACT-B) quality of life instrument. Behav Med. 1997;15(3):974–86.

    CAS  Google Scholar 

  82. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer. 1995;75(5):1151–61.

    Article  PubMed  CAS  Google Scholar 

  83. Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res. 1999;8(3):181–95.

    Article  PubMed  CAS  Google Scholar 

  84. Darling G, Eton D, Sulman J, Casson A, Cella D. Validation of the functional assessment of cancer therapy esophageal cancer. Cancer. 2006;107(4):854–63.

    Article  PubMed  Google Scholar 

  85. List MA, D’Antonio LL, Cella DF, et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer. 1996;77(11):2294–301.

    Article  PubMed  CAS  Google Scholar 

  86. Heffernan N, Cella D, Webster K, et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire. J Clin Oncol. 2002;20(9):2229–39.

    Article  PubMed  Google Scholar 

  87. Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer. 1995;12(3):199–220.

    Article  PubMed  CAS  Google Scholar 

  88. Webster K, Chivington K, Shonk C, et al. Measuring quality of life (QOL) among patients with leukemia: the Functional Assessment of Cancer Therapy-Leukemia (FACT-L). Qual Life Res. 2002;11:678.

    Google Scholar 

  89. Pettengell R, Donatti C, Hoskin P, et al. The impact of follicular lymphoma on health-related quality of life. Ann Oncol. 2008;19(3):570–6.

    Article  PubMed  CAS  Google Scholar 

  90. Cormier JN, Ross M, Gershenwald J, et al. Prospective assessment of the reliability, validity, and sensitivity to change of the functional assessment of cancer therapy-melanoma questionnaire. Cancer. 2008;112(10):2249–57.

    Article  PubMed  Google Scholar 

  91. Tong MC, Lo PS, Wong KH, et al. Development and validation of the functional assessment of cancer therapy nasopharyngeal cancer subscale. Head Neck. 2009;31(6):738–47.

    Article  PubMed  Google Scholar 

  92. Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian. J Clin Oncol. 2001;19(6):1809–17.

    PubMed  CAS  Google Scholar 

  93. Janda M, Obermair A, Cella D, et al. The functional assessment of cancer-vulvar: reliability and validity. Gynecol Oncol. 2005;97(2):568–75.

    Article  PubMed  Google Scholar 

  94. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol. 1984;2(5):472–83.

    PubMed  CAS  Google Scholar 

  95. Eton DT, Lepore SJ. Prostate cancer and health-related quality of life: a review of the literature. Psychooncology. 2002;11(4):307–26.

    Article  PubMed  Google Scholar 

  96. Morrow GR, Lindke J, Black P. Measurement of quality of life in patients: psychometric analyses of the Functional Living Index-Cancer (FLIC). Qual Life Res. 1992;1(5):287–96.

    Article  PubMed  CAS  Google Scholar 

  97. Clinch JJ. The Functional Living Index – Cancer: ten years later. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials, vol. 2. Philadelphia: Lippincott-Raven Publishers; 1996. p. 215–25.

    Google Scholar 

  98. Laenen A, Alonso A. The Functional Living Index-Cancer: estimating its reliability based on clinical trial data. Qual Life Res. 2010;19(1):103–9.

    Article  PubMed  Google Scholar 

  99. Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat. 1996;38(2):183–99.

    Article  PubMed  CAS  Google Scholar 

  100. Turner S, Gruenewald S, Spry N, Gebski V. Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer. Br J Cancer. 2001;84(3):297–302.

    Article  PubMed  CAS  Google Scholar 

  101. Siddiqui F, Kohl R, Swann S, Watkins-Bruner D, Movsas B. Gender differences in pretreatment quality of life in a prospective lung cancer trial. J Support Oncol. 2008;6(1):33–9.

    PubMed  Google Scholar 

  102. Leake RL, Gurrin LC, Hammond IG. Quality of life in patients attending a low-risk gynaecological oncology follow-up clinic. Psychooncology. 2001;10(5):428–35.

    Article  PubMed  CAS  Google Scholar 

  103. Cohen SR, Mount BM, Strobel MG, Bui F. The McGill Quality of Life questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med. 1995;9(3):207–19.

    Article  PubMed  CAS  Google Scholar 

  104. Cohen SR, Mount BM, Bruera E, Provost M, Rowe J, Tong K. Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med. 1997;11(1):3–20.

    Article  PubMed  Google Scholar 

  105. Cohen SR, Mount BM. Living with cancer: “good” days and “bad” days – what produces them? Can the McGill quality of life questionnaire distinguish between them? Cancer. 2000;89(8):1854–65.

    Article  PubMed  CAS  Google Scholar 

  106. Jones JM, McPherson CJ, Zimmermann C, Rodin G, Le LW, Cohen SR. Assessing agreement between terminally ill cancer patients’ reports of their quality of life and family caregiver and palliative care physician proxy ratings. J Pain Symptom Manage. 2011;42(3):354–65.

    Article  PubMed  Google Scholar 

  107. Lowe SS, Watanabe SM, Baracos VE, Courneya KS. Associations between physical activity and quality of life in cancer patients receiving palliative care: a pilot survey. J Pain Symptom Manage. 2009;38(5):785–96.

    Article  PubMed  Google Scholar 

  108. Husain AF, Stewart K, Arseneault R, et al. Women experience higher levels of fatigue than men at the end of life: a longitudinal home palliative care study. J Pain Symptom Manage. 2007;33(4):389–97.

    Article  PubMed  Google Scholar 

  109. Sherman DW, Ye XY, McSherry C, Parkas V, Calabrese M, Gatto M. Quality of life of patients with advanced cancer and acquired immune deficiency syndrome and their family caregivers. J Palliat Med. 2006;9(4):948–63.

    Article  PubMed  Google Scholar 

  110. Ferrans CE, Powers MJ. Quality of life index: development and psychometric properties. Adv Nurs Sci. 1985;8(1):15–24.

    CAS  Google Scholar 

  111. Ferrans CE. Development of a quality of life index for patients with cancer. Oncol Nurs Forum. 1990;17(3 Suppl):15–9.

    PubMed  CAS  Google Scholar 

  112. Ferrans CE, Powers MJ. Psychometric assessment of the Quality of Life Index. Res Nurs Health. 1992;15(1):29–38.

    Article  PubMed  CAS  Google Scholar 

  113. Lis C, Gupta D, Granick J, Grutsch J. Can patient satisfaction with quality of life predict survival in advanced colorectal cancer? Support Care Cancer. 2006;14(11):1104–10.

    Article  PubMed  Google Scholar 

  114. Sammarco A. Quality of life among older survivors of breast cancer. Cancer Nurs. 2003;26(6):431–8.

    Article  PubMed  Google Scholar 

  115. Gupta D, Granick J, Grutsch J, Lis C. The prognostic association of health-related quality of life scores with survival in breast cancer. Support Care Cancer. 2007;15(4):387–93.

    Article  PubMed  Google Scholar 

  116. Warnecke RB, Ferrans CE, Johnson TP, et al. Measuring quality of life in culturally diverse populations. J Natl Cancer Inst Monogr. 1996;20:29–38.

    PubMed  Google Scholar 

  117. Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(11 Suppl):2577–92.

    Article  PubMed  Google Scholar 

  118. Hewitt M, Greenfield S, Stovall E, Institute of Medicine (U.S.), American Society of Clinical Oncology. From cancer patient to cancer survivor: lost in transition. Washington, D.C.: National Academies Press; 2006.

    Google Scholar 

  119. Baker F, Denniston M, Zabora JR, Marcellus D. Cancer problems in living and quality of life after bone marrow transplantation. J Clin Psychol Med Settings. 2003;10(1):27–34.

    Article  Google Scholar 

  120. Zhao L, Stein K, Smith T, Portier K, Baker F. Exploratory factor analysis of the cancer problems in living scale: a report from the American Cancer Society’s studies of cancer survivors. J Pain Symptom Manage. 2009;37(4):676–86.

    Article  PubMed  Google Scholar 

  121. Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104(S11):2565–76.

    Article  PubMed  Google Scholar 

  122. Smith T, Stein KD, Mehta CC, et al. The rationale, design, and implementation of the American Cancer Society’s studies of cancer survivors. Cancer. 2007;109(1):1–12.

    Article  PubMed  Google Scholar 

  123. Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psychooncology. 2006;15(5):407–21.

    Article  PubMed  Google Scholar 

  124. Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B. Refinement and psychometric evaluation of the impact of cancer scale. J Natl Cancer Inst. 2008;100(21):1530–41.

    Article  PubMed  Google Scholar 

  125. Zebrack BJ, Yi J, Petersen L, Ganz PA. The impact of cancer and quality of life for long-term survivors. Psychooncology. 2008;17(9):891–900.

    Article  PubMed  Google Scholar 

  126. Crespi CM, Petersen L, Ganz PA, Smith SK, Zimmerman S. Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors. J Cancer Surviv. 2010;4(1):45–58.

    Article  PubMed  Google Scholar 

  127. Zebrack BJ, Donohue JE, Gurney JG, Chesler MA, Bhatia S, Landier W. Psychometric evaluation of the impact of cancer (IOC-CS) scale for young adult survivors of childhood cancer. Qual Life Res. 2010;19(2):207–18.

    Article  PubMed  Google Scholar 

  128. Zebrack B. Developing a new instrument to assess the impact of cancer in young adult survivors of childhood cancer. J Cancer Surviv. 2009;3(3):174–80.

    Article  PubMed  Google Scholar 

  129. Wyatt GK, Friedman LL. Development and testing of a quality of life model for long-term female cancer survivors. Qual Life Res. 1996;5(3):387–94.

    Article  PubMed  CAS  Google Scholar 

  130. Wyatt G, Friedman LL. Long-term female cancer survivors: quality of life issues and clinical implications. Cancer Nurs. 1996;19(1):1–7.

    Article  PubMed  CAS  Google Scholar 

  131. Wyatt G, Kurtz ME, Friedman LL, Given B, Given CW. Preliminary testing of the Long-Term Quality of Life (LTQL) instrument for female cancer survivors. J Nurs Meas. 1996;4(2):153–70.

    PubMed  CAS  Google Scholar 

  132. Avis NE, Smith KW, McGraw S, Smith RG, Petronis VM, Carver CS. Assessing quality of life in adult cancer survivors (QLACS). Qual Life Res. 2005;14(4):1007–23.

    Article  PubMed  Google Scholar 

  133. Avis NE, Ip E, Foley KL. Evaluation of the quality of life in adult cancer survivors (QLACS) scale for long-term cancer survivors in a sample of breast cancer survivors. Health Qual Life Outcomes. 2006;4:92.

    Article  PubMed  Google Scholar 

  134. Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4(6):523–31.

    Article  PubMed  CAS  Google Scholar 

  135. Ferrell BR, Dow KH, Leigh S, Ly J, Gulasekaram P. Quality of life in long-term cancer survivors. Oncol Nurs Forum. 1995;22(6):915–22.

    PubMed  CAS  Google Scholar 

  136. Whedon M, Stearns D, Mills LE. Quality of life of long-term adult survivors of autologous bone marrow transplantation. Oncol Nurs Forum. 1995;22(10):1527–35.

    PubMed  CAS  Google Scholar 

  137. Zebrack B, Chesler M. A psychometric analysis of the quality of life-cancer survivors (QOL-CS) in survivors of childhood cancer. Qual Life Res. 2001;10(4):319–29.

    Article  PubMed  CAS  Google Scholar 

  138. Litwin MS, Hays R, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of health-related quality of life measure. Med Care. 1998;26(7):1002–12.

    Article  Google Scholar 

  139. Terrell JE, Nanavati KA, Esclamado RM, Bishop JK, Bradford CR, Wolf GT. Head and neck cancer-specific quality of life: instrument validation. Arch Otolaryngol Head Neck Surg. 1997;123(10):1125–32.

    Article  PubMed  CAS  Google Scholar 

  140. Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer. 1993;29A Suppl 1:S51–8.

    Google Scholar 

  141. Davidson-Homewood J, Norman A, Küchler T, Cunningham D, Watson M. Development of a disease specific questionnaire to supplement a generic tool for QoL in colorectal cancer. Psychooncology. 2003;12(7):675–85.

    Article  PubMed  CAS  Google Scholar 

  142. McCorkle R. The measurement of symptom distress. Semin Oncol Nurs. 1987;3(4):248–56.

    Article  PubMed  CAS  Google Scholar 

  143. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs. 1978;1(5):373–8.

    Article  PubMed  CAS  Google Scholar 

  144. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634–46.

    Article  PubMed  CAS  Google Scholar 

  145. Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton symptom assessment scale. Cancer. 2000;88(9):2164–71.

    Article  PubMed  CAS  Google Scholar 

  146. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A(9):1326–36.

    Article  PubMed  CAS  Google Scholar 

  147. De Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990;62(6):1034–8.

    Article  PubMed  Google Scholar 

  148. Derogatis LR. SCL-90-R: administration, scoring, and procedures manual I for the revised version of the SCL-90. Baltimore, MD: Johns Hopkins University Press; 1977.

    Google Scholar 

  149. Derogatis LR, Spencer MS. The Brief Symptom Inventory (BSI): administration, scoring, and procedures manual. Baltimore: Johns Hopkins University School of Medicine, Clinical Psychometrics Research Unit; 1982.

    Google Scholar 

  150. Zabora J, BrintzenhofeSzoc K, Jacobsen P, et al. A new psychosocial screening instrument for use with cancer patients. Psychosomatics. 2001;42(3):241–6.

    Article  PubMed  CAS  Google Scholar 

  151. McNair DM, Lorr M, Droppleman LF. Profile of mood states (POMS). San Diego, CA: Educational and Industrial Testing Service; 1992.

    Google Scholar 

  152. Veit CT, Ware Jr JE. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol. 1983;51(5):730–42.

    Article  PubMed  CAS  Google Scholar 

  153. Bradburn NM. The structure of psychological well-being. Chicago, IL: Aldine Publishing; 1969.

    Google Scholar 

  154. Bradburn NM, Caplovitz D. Reports on happiness: a pilot study of behavior related to mental health. Chicago, IL: Aldine; 1965.

    Google Scholar 

  155. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement. 1977;1(3):385–401.

    Article  Google Scholar 

  156. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    Article  PubMed  CAS  Google Scholar 

  157. Spielberger CD, Gorsuch RL, Lushene RE. STAI manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.

    Google Scholar 

  158. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209–18.

    PubMed  CAS  Google Scholar 

  159. Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD Checklist (PCL). Behav Res Ther. 1996;34(8):669–73.

    Article  PubMed  CAS  Google Scholar 

  160. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer. 1999;85(5):1186–96.

    Article  PubMed  CAS  Google Scholar 

  161. Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med. 1994;23(2):129–38.

    CAS  Google Scholar 

  162. Armstrong FD, Toledano SR, Miloslavich K, et al. The Miami pediatric quality of life questionnaire: parent scale. Int J Cancer Suppl. 1999;12:11–7.

    Article  PubMed  CAS  Google Scholar 

  163. Bhatia S, Jenney ME, Bogue MK, et al. The Minneapolis-Manchester quality of life instrument: reliability and validity of the adolescent form. J Clin Oncol. 2002;20(24):4692–8.

    Article  PubMed  Google Scholar 

  164. Bhatia S, Jenney ME, Wu E, et al. The Minneapolis-Manchester quality of life instrument: reliability and validity of the youth form. J Pediatr. 2004;145(1):39–46.

    Article  PubMed  Google Scholar 

  165. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002;94(7):2090–106.

    Article  PubMed  Google Scholar 

  166. Varni JW, Katz ER, Seid M, Quiggins DJ, Friedman-Bender A. The pediatric cancer quality of life inventory-32 (PCQL-32): I. Reliability and validity. Cancer. 1998;82(6):1184–96.

    Article  PubMed  CAS  Google Scholar 

  167. Varni JW, Katz ER, Seid M, Quiggins DJ, Friedman-Bender A, Castro CM. The Pediatric Cancer Quality of Life Inventory (PCQL). I. Instrument development, descriptive statistics, and cross-informant variance. J Behav Med. 1998;21(2):179–204.

    Article  PubMed  CAS  Google Scholar 

  168. Varni JW, Rode CA, Seid M, Katz ER, Friedman-Bender A, Quiggins DJL. The Pediatric Cancer Quality of Life Inventory-32 (PCQL-32). II. Feasibility and range of measurement. J Behav Med. 1999;22(4):397–406.

    Article  PubMed  CAS  Google Scholar 

  169. Goodwin DA, Boggs SR, Boggs SR, Graham-Pole J. Development and validation of the pediatric oncology quality of life scale. Psychol Assess. 1994;6(4):321–8.

    Article  Google Scholar 

  170. Bijttebier P, Vercruysse T, Vertommen H, Gool SWV, Uyttebroeck A, Brock P. New evidence on the reliability and validity of the pediatric oncology quality of life scale. Psychol Health. 2001;16(4):461.

    Article  Google Scholar 

  171. Klassen A, Strohm S, Maurice-Stam H, Grootenhuis M. Quality of life questionnaires for children with cancer and childhood cancer survivors: a review of the development of available measures. Support Care Cancer. 2010;18(9):1207–17.

    Article  PubMed  Google Scholar 

  172. Trask PC, Hsu MA, McQuellon R. Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance. Cancer J. 2009;15(5):435–40.

    Article  PubMed  Google Scholar 

  173. Silveira AP, Gonçalves J, Sequeira T, et al. Patient reported outcomes in head and neck cancer: selecting instruments for quality of life integration in clinical protocols. Head Neck Oncol. 2010;2(32):1–9.

    Google Scholar 

  174. Aaronson NK. Quality of life: what is it? How should it be measured? Oncology. 1988;2(5):69–76.

    PubMed  CAS  Google Scholar 

  175. Bergman B, Sullivan M, Sörenson S. Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC core quality of life questionnaire and comparison with the sickness impact profile. Acta Oncol. 1992;31(1):19–28.

    Article  PubMed  CAS  Google Scholar 

  176. Boini S, Briancon S, Guillemin F, Galan P, Hercberg S. Impact of cancer occurrence on health-related quality of life: a longitudinal pre-post assessment. Health Qual Life Outcomes. 2004;2(1):4.

    Article  PubMed  Google Scholar 

  177. Andrykowski MA, Brady MJ, Hunt JW. Positive psychosocial adjustment in potential bone marrow transplant recipients: cancer as a psychosocial transition. Psychooncology. 1993;2(261):276.

    Google Scholar 

  178. Lee L, Chung C-W, Chang Y-Y, et al. Comparison of the quality of life between patients with non-small-cell lung cancer and healthy controls. Qual Life Res. 2011;20(3):415–23.

    Article  PubMed  Google Scholar 

  179. Anastasi A, Urbina S. Psychological testing. Upper Saddle River, NJ: Prentice Hall; 1997.

    Google Scholar 

  180. Lord FM. Applications of item response theory to practical testing problems. Hillsdale, NJ: Lawrence Erlbaum; 1980.

    Google Scholar 

  181. Richardson M. The relation between the difficulty and the differential validity of a test. Psychometrika. 1936;1(2):33–49.

    Article  Google Scholar 

  182. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford, New York: Oxford University Press; 1995.

    Google Scholar 

  183. Cella D, Riley W, Stone A, et al. The Patient Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–94.

    Article  PubMed  Google Scholar 

  184. Liu H, Cella D, Gershon R, et al. Representativeness of the PROMIS internet panel. J Clin Epidemiol. 2010;63(11):1169–78.

    Article  PubMed  Google Scholar 

  185. Rothrock N, Hays R, Spritzer K, Yount SE, Riley W, Cella D. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol. 2010;63(11):1195–204.

    Article  PubMed  Google Scholar 

  186. Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007;45(5 Suppl 1):S3–11.

    Article  PubMed  Google Scholar 

  187. DeWalt DA, Rothrock N, Yount S, Stone AA, PROMIS Cooperative Group. Evaluation of item candidates: the PROMIS qualitative item review. Med Care. 2007;45(5 Suppl 1):S12–21.

    Article  PubMed  Google Scholar 

  188. Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 Suppl 1):S22–31.

    Article  PubMed  Google Scholar 

  189. Wilkie DJ, Huang HY, Berry DL, et al. Cancer symptom control: feasibility of a tailored, interactive computerized program for patients. Fam Community Health. 2001;24(3):48–62.

    PubMed  CAS  Google Scholar 

  190. Cleeland CS. Cancer-related symptoms. Semin Radiat Oncol. 2000;10(3):175–90.

    Article  PubMed  CAS  Google Scholar 

  191. Passik SD, Kirsh KL, Donaghy K, et al. Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire. J Pain Symptom Manage. 2002;24(5):481–93.

    Article  PubMed  Google Scholar 

  192. Beckman HB, Frankel RM. The effect of physician behavior on the collection of data. Ann Intern Med. 1984;101(5):692–6.

    PubMed  CAS  Google Scholar 

  193. Dalton JA, Blau W, Carlson J, et al. Changing the relationship among nurses’ knowledge, self-reported behavior, and documented behavior in pain management: does education make a difference? J Pain Symptom Manage. 1996;12(5):308–19.

    Article  PubMed  CAS  Google Scholar 

  194. Schuit KW, Sleijfer DT, Meijler WJ, et al. Symptoms and functional status of patients with disseminated cancer visiting outpatient departments. J Pain Symptom Manage. 1998;16(5):290–7.

    Article  PubMed  CAS  Google Scholar 

  195. Whelan TJ, Mohide EA, Willan AR, et al. The supportive care needs of newly diagnosed cancer patients attending a regional cancer center. Cancer. 1997;80(8):1518–24.

    Article  PubMed  CAS  Google Scholar 

  196. Thomason TE, McCune JS, Bernard SA, Winer EP, Tremont S, Lindley CM. Cancer pain survey: patient-centered issues in control. J Pain Symptom Manage. 1998;15(5):275–84.

    Article  PubMed  CAS  Google Scholar 

  197. Cleeland CS. Barriers to the management of cancer pain. Oncology. 1987;1(2 Suppl):19–26.

    PubMed  CAS  Google Scholar 

  198. Riddell A, Fitch MI. Patients’ knowledge of and attitudes toward the management of cancer pain. Oncol Nurs Forum. 1997;24(10):1775–84.

    PubMed  CAS  Google Scholar 

  199. Twycross R, Lack S. Symptom control in far advanced cancer: pain relief. London: Raven Pitman; 1984.

    Google Scholar 

  200. Diekmann JM, Engber D, Wassem R. Cancer pain control: one state’s experience. Oncol Nurs Forum. 1989;16(2):219–23.

    PubMed  CAS  Google Scholar 

  201. Ward SE, Goldberg N, Miller-McCauley V, et al. Patient-related barriers to management of cancer pain. Pain. 1993;52(3):319–24.

    Article  PubMed  CAS  Google Scholar 

  202. von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993;119(2):121–6.

    Google Scholar 

  203. Jacox A, Carr DB, Payne R. New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med. 1994;330(9):651–5.

    Article  PubMed  CAS  Google Scholar 

  204. Fortner BV, Schwartzberg LS, Stepanski EJ, Houts AC. Symptom burden for patients with metastatic colorectal cancer treated with first-line FOLFOX or FOLFIRI with and without Bevacizumab in the community setting. Support Cancer Ther. 2007;4(4):233–40.

    Article  PubMed  CAS  Google Scholar 

  205. Detmar SB, Aaronson NK. Quality of life assessment in daily clinical oncology practice: a feasibility study. Eur J Cancer. 1998;34(8):1181–6.

    Article  PubMed  CAS  Google Scholar 

  206. Velikova G, Brown JM, Smith AB, Selby PJ. Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br J Cancer. 2002;86(1):51–9.

    Article  PubMed  CAS  Google Scholar 

  207. Carlson LE, Speca M, Hagen N, Taenzer P. Computerized quality-of-life screening in a cancer pain clinic. J Palliat Care. 2001;17(1):46–52.

    PubMed  CAS  Google Scholar 

  208. Davis K, Cella D, Yount S, et al. Computer technology as a platform for weekly symptom monitoring of patients with advanced lung cancer. Lung Cancer. 2003;41(S2):S266.

    Article  Google Scholar 

  209. Detmar SB, Muller M, Wever LD, Schornagel JH, Aaronson NK. Patient-Physician communication during outpatient palliative treatment visits: an observational study. J Am Med Assoc. 2001;285(10):1351–7.

    Article  CAS  Google Scholar 

  210. Taenzer P, Speca M, Atkinson M, et al. Computerized quality of life screening in an oncology clinic. Cancer Pract. 1997;5(3):168–75.

    PubMed  CAS  Google Scholar 

  211. Naughton M, Homsi J. Symptom assessment in cancer patients. Curr Oncol Rep. 2002;4:256–63.

    Article  PubMed  Google Scholar 

  212. Brown V, Sitzia J, Richardson A, Hughes J, Hannon H, Oakley C. The development of the Chemotherapy Symptom Assessment Scale (C-SAS): a scale for the routine clinical assessment of the symptom experiences of patients receiving cytotoxic chemotherapy. Int J Nurs Stud. 2001;38:497–510.

    Article  PubMed  CAS  Google Scholar 

  213. Detmar SB, Aaronson N, Wever LD, Muller M, Schornagel JH. How are you feeling? Who wants to know? Patients’ and oncologists’ preferences for discussing health-related quality of life issues. J Clin Oncol. 2000;18(18):3295–301.

    PubMed  CAS  Google Scholar 

  214. Montazeri A, Gillis CR, McEwen J. Measuring quality of life in oncology: is it worthwhile? Experiences from the treatment of cancer. Eur J Cancer Care. 1996;5(3):168–75.

    Article  CAS  Google Scholar 

  215. Street RL, Gold WR, McDowell T. Using health surveys in medical consultations. Med Care. 1994;32(7):732–44.

    Article  PubMed  Google Scholar 

  216. Detmar SB, Muller MJ, Wever LD, Schornagel JH, Aaronson NK. The patient-physician relationship. Patient-physician communication during outpatient palliative treatment visits: an observational study. JAMA. 2001;285(10):1351–7.

    Article  PubMed  CAS  Google Scholar 

  217. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA. 2002;288(23):3027–34.

    Article  PubMed  Google Scholar 

  218. Rosenbloom S, Victorson D, Hahn E, Peterman A, Cella D. Assessment is not enough: a randomized controlled trial of the effects of HRQL assessment on quality of life and satisfaction in oncology clinical practice. Psychooncology. 2007;16(12):1069–79.

    Article  PubMed  Google Scholar 

  219. Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22(4):714–24.

    Article  PubMed  Google Scholar 

  220. Mooney KH, Beck SL, Friedman RH, Farzanfar R. Telephone-linked care for cancer symptom monitoring: a pilot study. Cancer Pract. 2002;10(3):147–54.

    Article  PubMed  Google Scholar 

  221. Taenzer P, Bultz BD, Carlson LE, et al. Impact of computerized quality of life screening on physician behavior and patient satisfaction in lung cancer outpatients. Psychooncology. 2000;9(3):203–13.

    Article  PubMed  CAS  Google Scholar 

  222. VonRoenn J, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993;119:121–6.

    CAS  Google Scholar 

  223. Cella D, Paul D, Yount S, et al. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Invest. 2003;21(4):526–35.

    Article  PubMed  Google Scholar 

  224. Aarstad AKH, Aarstad HJ, Beisland E, Osthus AA. Distress, quality of life, neuroticism and psychological coping are related in head and neck cancer patients during follow-up. Acta Oncol. 2011;50(3):390–8.

    Article  PubMed  Google Scholar 

  225. Meyer F, Fortin A, Gelinas M, et al. Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy. J Clin Oncol. 2009;27(18):2970–6.

    Article  PubMed  Google Scholar 

  226. Chan JYK, Lua LL, Starmer HH, Sun DQ, Rosenblatt ES, Gourin CG. The relationship between depressive symptoms and initial quality of life and function in head and neck cancer. Laryngoscope. 2011;121(6):1212–8.

    Article  PubMed  Google Scholar 

  227. Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res. 1988;111:231–49.

    Article  PubMed  CAS  Google Scholar 

  228. Au H-J, Ringash J, Brundage M, Palmer M, Richardson H, Meyer RM. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG. Expert Rev Pharmacoecon Outcomes Res. 2010;10(2):119–28.

    Article  PubMed  Google Scholar 

  229. Joly F, Vardy J, Pintilie M, Tannock IF. Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Ann Oncol. 2007;18(12):1935–42.

    Article  PubMed  CAS  Google Scholar 

  230. Efficace F, Osoba D, Gotay C, Sprangers M, Coens C, Bottomley A. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Ann Oncol. 2007;18(4):775–81.

    Article  PubMed  CAS  Google Scholar 

  231. Gotay CC. Assessing cancer-related quality of life across a spectrum of applications. J Natl Cancer Inst Monogr. 2004;33:126–33.

    Article  PubMed  Google Scholar 

  232. Dwivedi R, St. Rose S, Chisholm E, et al. Evaluation of factors affecting post-treatment quality of life in oral and oropharyngeal cancer patients primarily treated with curative surgery: an exploratory study. Eur Arch Otorhinolaryngol. 2012;269(2):591–9.

    Article  PubMed  Google Scholar 

  233. Tschiesner U, Becker S, Berghaus A, et al. Content validation of the International Classification of Functioning, Disability and Health core sets for head and neck cancer: a multicentre study. J Otolaryngol Head Neck Surg. 2010;39(6):674–87.

    PubMed  Google Scholar 

  234. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–15.

    Article  PubMed  CAS  Google Scholar 

  235. Yost KJ, Eton DT. Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience. Eval Health Prof. 2005;28(2):172–91.

    Article  PubMed  Google Scholar 

  236. Yost KJ, Eton DT, Garcia SF, Cella D. Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol. 2011;64(5):507–16.

    Article  PubMed  Google Scholar 

  237. Beitz J. Quality-of-life end points in oncology drug trials. Oncology. 1999;13(10):1439.

    PubMed  CAS  Google Scholar 

  238. U. S. Food and Drug Administration, Center for Drug Evaluation and Research. Meeting of the Quality of Life Subcommittee of the Oncologic Drugs Advisory Committee. 2000. http://www.fda.gov/ohrms/dockets/ac/cder00.htm#Oncologic%20Drugs%20Advisory%20Committee. Accessed 1 Jul 2010.

  239. Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health. 1999;2(2):113–26.

    Article  PubMed  CAS  Google Scholar 

  240. Brunelli C, Costantini M, Di Giulio P, et al. Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symp Manage. 1998;15(3):151–8.

    Article  CAS  Google Scholar 

  241. Stephens RJ, Hopwood P, Girling DJ, Machin D. Randomized trials with quality of life endpoints: are doctors’ ratings of patients’ physical symptoms interchangeable with patients’ self- ratings? Qual Life Res. 1997;6(3):225–36.

    Article  PubMed  CAS  Google Scholar 

  242. Stromgren AS, Groenvold M, Sorensen A, Andersen L. Symptom recognition in advanced cancer. A comparison of nursing records against patient self-rating. Acta Anaesthesiol Scand. 2001;45(9):1080–5.

    Article  PubMed  CAS  Google Scholar 

  243. Cella D, Rosenbloom SK, Beaumont JL, et al. Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer. J Natl Compr Canc Netw. 2011;9(3):268–78.

    PubMed  Google Scholar 

  244. Rao D, Butt Z, Rosenbloom S, et al. A comparison of the renal cell carcinoma symptom index (RCC-SI) and the functional assessment of cancer therapy – kidney symptom index (FKSI). J Pain Symptom Manage. 2009;38(2):291–8.

    Article  PubMed  Google Scholar 

  245. Yount S, Beaumont J, Rosenbloom S, et al. A brief symptom index for advanced lung cancer. Clin Lung Cancer. 2012;13(1):14–23.

    Article  PubMed  Google Scholar 

  246. Jensen SE, Rosenbloom SK, Beaumont JL, et al. A new index of priority symptoms in advanced ovarian cancer. Gynecol Oncol. 2011;120(2):214–9.

    Article  PubMed  Google Scholar 

  247. Victorson DE, Beaumont JL, Rosenbloom SK, Shevrin D, Cella D. Efficient assessment of the most important symptoms in advanced prostate cancer: the NCCN/FACT-P symptom index. Psychooncology. 2011;20(9):977–83.

    PubMed  Google Scholar 

  248. Collins LG, Swartz K. Caregiver care. Am Fam Physician. 2011;83(11):1309–17.

    PubMed  Google Scholar 

  249. Kim Y, Given BA. Quality of life of family caregivers of cancer survivors: across the trajectory of the illness. Cancer. 2008;112(11):2556–68.

    Article  PubMed  Google Scholar 

  250. Trask PC, Pearman T. Depression. In: Feuerstein M, editor. Handbook of cancer survivorship. New York, N.Y: Springer; 2007. p. 173–90.

    Chapter  Google Scholar 

  251. Kim Y, Baker F, Spillers RL. Cancer caregivers’ quality of life: effects of gender, relationship, and appraisal. J Pain Symptom Manage. 2007;34(3):294–304.

    Article  PubMed  Google Scholar 

  252. Song JI, Shin DW, Choi JY, et al. Quality of life and mental health in family caregivers of patients with terminal cancer. Support Care Cancer. 2011;19(10):1519–26.

    Article  PubMed  Google Scholar 

  253. Fridriksdottir N, Saevarsdottir P, Halfdanardottir SI, et al. Family members of cancer patients: needs, quality of life and symptoms of anxiety and depression. Acta Oncol. 2011;50(2):252–8.

    Article  Google Scholar 

  254. Kim Y, Wellisch D, Spillers R, Crammer C. Psychological distress of female cancer caregivers: effects of type of cancer and caregivers’ spirituality. Support Care Cancer. 2007;15(12):1367–74.

    Article  PubMed  Google Scholar 

  255. Kim Y, Spillers RL. Quality of life of family caregivers at 2 years after a relative’s cancer diagnosis. Psychooncology. 2010;19(4):431–40.

    Article  PubMed  Google Scholar 

  256. Kim Y, Carver C, Spillers R, Love-Ghaffari M, Kaw C-K. Dyadic effects of fear of recurrence on the quality of life of cancer survivors and their caregivers. Qual Life Res. 2012;21(3):517–25.

    Article  PubMed  Google Scholar 

  257. Eyigor S, Karapolat H, Yesil H, Kantar M. The quality of life and psychological status of mothers of hospitalized pediatric oncology patients. Pediatr Hematol Oncol. 2011;28(5):428–38.

    Article  PubMed  Google Scholar 

  258. Litzelman K, Catrine K, Gangnon R, Witt W. Quality of life among parents of children with cancer or brain tumors: the impact of child characteristics and parental psychosocial factors. Qual Life Res. 2011;20(8):1261–9.

    Article  PubMed  Google Scholar 

  259. Palos GR, Hare M. Patients, family caregivers, and patient navigators. Cancer. 2011;117(S15):3590–600.

    Article  Google Scholar 

  260. Meyers FJ, Carducci M, Loscalzo MJ, Linder J, Greasby T, Beckett LA. Effects of a Problem-Solving Intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: Simultaneous Care Educational Intervention (SCEI): linking palliation and clinical trials. J Palliat Med. 2011;14(4):465–73.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Social Sciences, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, 625 North Michigan Avenue, Suite 2700, Chicago, IL, 60611-3110, USA

    John M. Salsman Ph.D., Timothy Pearman Ph.D. & David Cella Ph.D.

  2. Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Timothy Pearman Ph.D.

  3. Department of Psychiatry and Behavioral Sciences, Institute for Healthcare Studies, Chicago, IL, USA

    David Cella Ph.D.

  4. Division of Health and Biomedical Informatics, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    David Cella Ph.D.

Authors
  1. John M. Salsman Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy Pearman Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Cella Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John M. Salsman Ph.D. .

Editor information

Editors and Affiliations

  1. Kimmel Cancer Center, Thomas Jefferson University, S. 10th Street 233, Philadelphia, 19107, Pennsylvania, USA

    Brian I. Carr

  2. STARZL TRANSPLAN INST, University of Pittsburgh, 5TH AVE 7 MONTEFIORE 3459, PITTSBURGH, 15213, Pennsylvania, USA

    JENNIFER STEEL

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Salsman, J.M., Pearman, T., Cella, D. (2013). Quality of Life. In: Carr, B., STEEL, J. (eds) Psychological Aspects of Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-4866-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4866-2_15

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-4865-5

  • Online ISBN: 978-1-4614-4866-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation